Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kami Maddocks, MD
Ohio State University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
- University of Maryland, Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- St. Joseph Mercy Hospital Cancer Care Center
Ypsilanti, Michigan, United States
- Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Ohio State University
Columbus, Ohio, United States
- Medical University of South Carolina - Hollings Cancer Center
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Sept 2018
- Primary completion
- 10 Nov 2025
- Completion
- 30 Aug 2026
- Last update posted
- 9 Apr 2026
- Registered enrollment
- 39
- Registry id
- NCT03478514
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.